After losing over $16 billion of market capitalization edwards lifesciences (ew) faces investor class action – hagens berman

San francisco, nov. 04, 2024 (globe newswire) -- hagens berman urges edwards lifesciences corporation (nyse: ew) investors who suffered substantial losses to submit your losses now. class period: feb. 6, 2024 – july 24, 2024 lead plaintiff deadline: dec. 13, 2024 visit: www.hbsslaw.com/investor-fraud/ew contact the firm now: ew@hbsslaw.com                                      844-916-0895 class action lawsuit against edwards lifesciences corporation (ew): the litigation is focused on the propriety of edwards lifesciences' disclosures about its core product, the transcatheter aortic valve replacement (“tavr”) platform.
EW Ratings Summary
EW Quant Ranking